The purpose of this study is to evaluate the safety and efficacy of buproprion in treating
individuals with adult attention-deficit hyperactivity disorder (ADHD) and cocaine
Please contact site for information.
Principal InvestigatorHerbert Kleber, M.D.New York State Psychiatric Institute
New York, New York 10032United StatesThere is no listed contact information for this specific location.Site Status: N/A
| All trademarks are property of their legal owners. | All Rights Reserved
ClinicalConnection.com is a resource that provides information on clinical trials conducted worldwide.
ClinicalConnection.com does not conduct or endorse clinical trials. Please consult your physician before participating.
© All Rights Reserved.
Terms of Service